Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a better vitamin mix beat iron pills for anemia in pregnancy?

NCT ID NCT07665957

Disease control Sponsor: Sindh Institute of Child Health and Neonatology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests whether a daily multiple micronutrient supplement (MMS) works better than standard iron-folic acid (IFA) pills—or a combination of both—to raise hemoglobin levels and improve newborn health. Researchers will enroll 402 pregnant women in Pakistan and follow them through delivery. The goal is to find the best nutritional strategy to prevent anemia and support healthy births.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multiple micronutrient supplement (MMS) and iron-folic acid (IFA)
What this could lead to
If MMS works better than IFA alone, it could lead to better pregnancy nutrition guidelines and reduce anemia and poor birth outcomes in low-resource settings.
What could go wrong
This is a small, early-stage trial in one country, so results may not apply elsewhere. Supplements may not significantly outperform standard care, and compliance can be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 402 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women aged 18 years or older * Gestational age ≤20 weeks at enrollment * Singleton pregnancy * Hemoglobin concentration ≥10 g/dL at baseline * Willing and able to provide informed consent * Willing to comply with study procedures and follow-up visits Exclusion Criteria: * Severe anemia requiring injectable treatment (hemoglobin \<7 g/dL) * Pre-existing diabetes mellitus * Pre-existing hypertension * Renal disease * Current therapeutic iron or micronutrient supplementation beyond routine antenatal supplementation * Known fetal congenital anomalies * Any medical condition that, in the opinion of the investigator, would interfere with study participation or outcome assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Maternal anemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Maternal anemia Maternal nutrition Micronutrient deficiency Pregnancy outcomes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.